Skip to main content

Table 5 Question overlap across PRioRiTy PSPs

From: What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study

 

PRioRiTy I ranking

PRioRiTy II ranking

Research question

A

6

 

What are the key motivators influencing members of the public’s decisions to take part in a randomised trial?

 

1

What motivates a participant’s decision to complete a clinical trial?

B

1

 

How can randomised trials become part of routine care and best utilise current clinical care pathways?

 

2

How can trials make better use of routine clinical care and/or existing data collection to improve retention?

C

3

 

Does patient/public involvement in planning a randomised trial improve recruitment?

 

5

How does involvement of patients/the public in planning and running trials improve retention?

D

10

 

What are the advantages and disadvantages to using technology during the recruitment process?

 

6

How could technology be best used in trial follow-up processes?

E

2

 

What information should trialists communicate to members of the public who are being invited to take part in a randomised trial in order to improve recruitment to the trial?

 

9

What information should trial teams communicate to potential trial participants to improve trial retention?

  1. The rows highlighted represent the priorities identified for trial retention